Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers

NCT02102932 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 5 mg empagliflozin/850 mg metformin FDC
DRUG: 12.5 mg empagliflozin
DRUG: 12.5 mg empagliflozin
DRUG: 850 mg metformin
DRUG: 5 mg empagliflozin
DRUG: 5 mg empagliflozin
DRUG: 850 mg metformin
DRUG: 12.5 mg empagliflozin/850 mg metformin FDC
DRUG: 12.5 mg empagliflozin/500 mg metformin FDC
DRUG: 5 mg empagliflozin/500 mg metformin FDC
DRUG: 500 mg metformin
DRUG: 500 mg metformin

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]